You are here

Symbicort

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort

Fierce Pharma

Fri, 12/16/22 - 11:08 am

AstraZeneca sues Mylan after securing fresh delivery patent on Symbicort

Fierce Pharma

Tue, 05/3/22 - 10:47 am

FDA clears first generic of AZ’s blockbuster Symbicort

Pharmaforum

Wed, 03/16/22 - 10:21 am

Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort

Fierce Pharma

Tue, 12/14/21 - 11:33 pm

AstraZeneca breathes sigh of relief as court blocks US Symbicort generic

Pharmaforum

Wed, 03/3/21 - 10:17 am

Propeller Health gets nod for use of sensor, app product with AstraZeneca inhaler

MedCity News

Tue, 05/26/20 - 11:10 am

Propeller Health

AstraZeneca cancer drugs build as primary care shrinks

Biopharma Dive

Mon, 08/12/19 - 12:08 pm

AstraZeneca Offers Outcomes-Based Pricing for Symbicort

Xtalks

Wed, 04/18/18 - 11:30 am

outcome-based pricing

FDA Pulls Boxed Warnings on Asthma Risks on Some Inhalers

RAPS.org

Thu, 12/21/17 - 10:35 pm

ICS/LABA inhalers

AstraZeneca’s Asthma Drug Receives Expanded Indication from FDA

Xtalks

Wed, 02/1/17 - 09:33 am

AZ nabs 6 more months of Symbicort exclusivity—and the sales that come with it

Fierce Pharma

Fri, 01/27/17 - 09:28 am

Why AstraZeneca’s Respiratory Segment Is a Key Growth Platform

Market Realist

Mon, 11/14/16 - 10:44 pm

AstraZeneca Announces Study Results Show SYMBICORT Improves Lung Function in Pediatric Asthma Patients

Yahoo

Fri, 11/11/16 - 09:47 am

AZ trumpets positive COPD data to help Symbicort stand up to rivals

Fierce Pharma

Tue, 08/16/16 - 09:22 am

Bad news for AstraZeneca: FDA lays out roadmap for would-be Symbicort copycats

Fierce Pharma

Wed, 07/1/15 - 04:10 pm

UK court backs Teva rival to AstraZeneca lung drug

Yahoo/Reuters

Wed, 09/3/14 - 08:12 am

Teva Pharmaceutical

With Teva's Symbicort copy nearing EU launch, AstraZeneca preps for battle

Fierce Pharma

Mon, 02/24/14 - 05:11 pm

Teva Pharmaceuticals

AstraZeneca Wins One Battle, But Loses Another (And Perhaps the War) on SYMBICORT Patent Term Extension

FDA Law Blog

Mon, 02/3/14 - 09:26 am

There’s A Patent Cliff But AstraZeneca Has A Jetpack

Motley Fool

Thu, 01/23/14 - 10:43 am

Merck Breathes Life Into an Acquired Pipeline

Motley Fool

Sat, 06/26/10 - 09:22 am

Pages